Raphael Koch

2.4k total citations
33 papers, 1.2k citations indexed

About

Raphael Koch is a scholar working on Molecular Biology, Oncology and Pathology and Forensic Medicine. According to data from OpenAlex, Raphael Koch has authored 33 papers receiving a total of 1.2k indexed citations (citations by other indexed papers that have themselves been cited), including 13 papers in Molecular Biology, 13 papers in Oncology and 8 papers in Pathology and Forensic Medicine. Recurrent topics in Raphael Koch's work include Lymphoma Diagnosis and Treatment (8 papers), T-cell and Retrovirus Studies (5 papers) and Chronic Lymphocytic Leukemia Research (5 papers). Raphael Koch is often cited by papers focused on Lymphoma Diagnosis and Treatment (8 papers), T-cell and Retrovirus Studies (5 papers) and Chronic Lymphocytic Leukemia Research (5 papers). Raphael Koch collaborates with scholars based in Germany, United States and United Kingdom. Raphael Koch's co-authors include Gerald Wulf, Bjoern Chapuy, Dirk Wenzel, Thiha Aung, Daniel Vogel, Timo Hupfeld, Lorenz Trümper, Lorenz Truemper, Toni Weinhage and Martin Oppermann and has published in prestigious journals such as Proceedings of the National Academy of Sciences, Nucleic Acids Research and Blood.

In The Last Decade

Raphael Koch

29 papers receiving 1.1k citations

Peers — A (Enhanced Table)

Peers by citation overlap · career bar shows stage (early→late) cites · hero ref

Name h Career Trend Papers Cites
Raphael Koch Germany 11 753 375 334 259 210 33 1.2k
Lorraine Tracey Spain 15 580 0.8× 266 0.7× 321 1.0× 216 0.8× 181 0.9× 20 1.1k
E B Bröcker Germany 19 653 0.9× 197 0.5× 442 1.3× 614 2.4× 270 1.3× 27 1.5k
Catalin Mihalcioiu Canada 14 391 0.5× 283 0.8× 422 1.3× 155 0.6× 75 0.4× 38 1000
Carol M. Amato United States 16 616 0.8× 327 0.9× 368 1.1× 268 1.0× 87 0.4× 34 1.0k
Nagesh Kalakonda United Kingdom 17 734 1.0× 98 0.3× 544 1.6× 153 0.6× 426 2.0× 52 1.4k
Walter Hanel United States 12 418 0.6× 225 0.6× 436 1.3× 287 1.1× 165 0.8× 39 910
Dina Stroopinsky United States 14 392 0.5× 144 0.4× 295 0.9× 315 1.2× 107 0.5× 46 835
Enkhtsetseg Purev United States 21 768 1.0× 184 0.5× 755 2.3× 308 1.2× 225 1.1× 55 1.6k
Jessica Dal Col Italy 20 469 0.6× 125 0.3× 554 1.7× 550 2.1× 202 1.0× 35 1.2k
Virginia Snell United States 14 542 0.7× 189 0.5× 391 1.2× 387 1.5× 249 1.2× 19 1.1k

Countries citing papers authored by Raphael Koch

Since Specialization
Citations

This map shows the geographic impact of Raphael Koch's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Raphael Koch with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Raphael Koch more than expected).

Fields of papers citing papers by Raphael Koch

Since Specialization
Physical SciencesHealth SciencesLife SciencesSocial Sciences

This network shows the impact of papers produced by Raphael Koch. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Raphael Koch. The network helps show where Raphael Koch may publish in the future.

Co-authorship network of co-authors of Raphael Koch

This figure shows the co-authorship network connecting the top 25 collaborators of Raphael Koch. A scholar is included among the top collaborators of Raphael Koch based on the total number of citations received by their joint publications. Widths of edges represent the number of papers authors have co-authored together. Node borders signify the number of papers an author published with Raphael Koch. Raphael Koch is excluded from the visualization to improve readability, since they are connected to all nodes in the network.

All Works

20 of 20 papers shown
1.
2.
3.
4.
5.
Denisova, Oxana V., Laxman Yetukuri, Amanpreet Kaur, et al.. (2023). PP2A ‐based triple‐strike therapy overcomes mitochondrial apoptosis resistance in brain cancer cells. Molecular Oncology. 17(9). 1803–1820. 5 indexed citations
6.
Shumilov, Evgenii, Justin Hasenkamp, Nicole Schmidt, et al.. (2022). Outcomes of second allogeneic stem cell transplantation and anti‐relapse strategies in patients with relapsed/refractory acute myeloid leukemia: A unicentric retrospective analysis. Hematological Oncology. 40(4). 763–776. 4 indexed citations
7.
Shumilov, Evgenii, Petra Hoffknecht, Raphael Koch, et al.. (2021). Diagnostic, Clinical and Post-SARS-CoV-2 Scenarios in Cancer Patients with SARS-CoV-2: Retrospective Analysis in Three German Cancer Centers. Cancers. 13(12). 2917–2917. 2 indexed citations
8.
Koch, Raphael, Stefan Welter, Marc Hinterthaner, et al.. (2021). Functional apoptosis profiling identifies MCL-1 and BCL-xL as prognostic markers and therapeutic targets in advanced thymomas and thymic carcinomas. BMC Medicine. 19(1). 300–300. 10 indexed citations
9.
He, Yonghan, Raphael Koch, Vivekananda Budamagunta, et al.. (2020). DT2216—a Bcl-xL-specific degrader is highly active against Bcl-xL-dependent T cell lymphomas. Journal of Hematology & Oncology. 13(1). 95–95. 92 indexed citations
10.
Shumilov, Evgenii, et al.. (2020). Patterns of Late Relapse after Allogeneic Hematopoietic Stem Cell Transplantation in Patients with T-Cell Prolymphocytic Leukemia. Acta Haematologica. 144(1). 105–110. 6 indexed citations
11.
12.
He, Yonghan, Raphael Koch, Vivekananda Budamagunta, et al.. (2019). DT2216, a BCL-XL Proteolysis Targeting Chimera (PROTAC), Is a Potent Anti T-Cell Lymphoma Agent That Does Not Induce Significant Thrombocytopenia. Blood. 134(Supplement_1). 303–303. 4 indexed citations
13.
Koch, Raphael, Amanda L. Christie, Jennifer L. Crombie, et al.. (2018). Biomarker-driven strategy for MCL1 inhibition in T-cell lymphomas. Blood. 133(6). 566–575. 35 indexed citations
14.
Horwitz, Steven M., Raphael Koch, Pierluigi Porcu, et al.. (2017). Activity of the PI3K-δ,γ inhibitor duvelisib in a phase 1 trial and preclinical models of T-cell lymphoma. Blood. 131(8). 888–898. 204 indexed citations
15.
Koch, Raphael, Elizabeth Brém, Rachael A. Clark, et al.. (2016). A Functional Characterization of BCL2-Family Members Identifies BH3 Mimetics As Potential Therapeutics in T-Cell Lymphomas. Blood. 128(22). 292–292. 2 indexed citations
16.
Koch, Raphael, Thiha Aung, Daniel Vogel, et al.. (2015). Nuclear Trapping through Inhibition of Exosomal Export by Indomethacin Increases Cytostatic Efficacy of Doxorubicin and Pixantrone. Clinical Cancer Research. 22(2). 395–404. 109 indexed citations
17.
Hasenkamp, Justin, et al.. (2014). Loss of donor chimerism in remission after allogeneic stem cell transplantation of T-prolymphocytic leukemia patients following alemtuzumab induction therapy. International Journal of Hematology. 100(5). 425–428. 4 indexed citations
18.
Chapuy, Bjoern, M. V. Panse, Ulf K Radunski, et al.. (2009). ABC transporter A3 facilitates lysosomal sequestration of imatinib and modulates susceptibility of chronic myeloid leukemia cell lines to this drug. Haematologica. 94(11). 1528–1536. 71 indexed citations
19.
Chapuy, Bjoern, Raphael Koch, Ulf K Radunski, et al.. (2008). Intracellular ABC transporter A3 confers multidrug resistance in leukemia cells by lysosomal drug sequestration. Leukemia. 22(8). 1576–1586. 120 indexed citations
20.
McElligott, David L., et al.. (1997). CD4+ T cells from IRF-1-deficient mice exhibit altered patterns of cytokine expression and cell subset homeostasis. The Journal of Immunology. 159(9). 4180–4186. 30 indexed citations

Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.

Explore authors with similar magnitude of impact

Breakdown of academic impact, for papers by Lorraine Tracey Breakdown of academic impact, for papers by E B Bröcker Breakdown of academic impact, for papers by Catalin Mihalcioiu Breakdown of academic impact, for papers by Carol M. Amato Breakdown of academic impact, for papers by Nagesh Kalakonda Breakdown of academic impact, for papers by Walter Hanel Breakdown of academic impact, for papers by Dina Stroopinsky Breakdown of academic impact, for papers by Enkhtsetseg Purev Breakdown of academic impact, for papers by Jessica Dal Col Breakdown of academic impact, for papers by Virginia Snell
Rankless by CCL
2026